📰 Human Use News
Page 117 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
September 3, 2022
The adapted COVID-19 vaccine targets both the original virus and the Omicron variant
September 2, 2022
(RTTNews) - Novavax Inc. (NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectio...
September 2, 2022
WASHINGTON (dpa-AFX) - Novavax Inc. (NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, said that Nuvaxovid (NVX-CoV2373)
September 1, 2022
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced a 30 µg booster dose of their Omicron BA.1- Bivalent COVID-19 Vaccine, COMIRNATY Original, has been recommended for
September 1, 2022
Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
September 1, 2022
CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccineThe Omicron BA.1-adapted bivalent COVID-19 vaccine combines 15-µg of mRNA encoding the SARS-CoV-2 wild-type spike protein which is in the Original Pfizer-BioNTech COVID-19 Vac...
September 1, 2022
CHMP recommendation based on safety, tolerability, and immunogenicity data from a Phase 2/3 trial of the Omicron BA.1-adapted bivalent vaccine The Omicron BA.1-adapted bivalent COVID-19 vaccine
September 1, 2022
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna's
September 1, 2022
Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 subvariants when compared with mRNA-1273Positive recommendation follows recent amendment
September 1, 2022
DGAP-News: Moderna, Inc. / Key word(s): Miscellaneous EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Modernas Omicron-Targeting Bivalent Booster in the European Union 01.09.2022 / 15:35 CET/CEST The issuer is solely re...